QURE News 9.00 Uniqure B.V. (QURE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Uniqure B.V. (QURE) 9.00 $QURE

Nasdaq stocks posting largest percentage decreases
AP - Wed Apr 16, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:

uniQure Announces Changes in Management Team
GlobeNewswire - Wed Apr 09, 6:08AM CDT
uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced the appointment of Eric Goossens as its new Chief Operating Officer with a primary responsibility for manufacturing and project management. Mr. Goossens has a 15-year track record of management and leadership in technology-based companies, including the biopharmaceutical industry, with particular experience in the oversight of operations and site management. In addition, uniQure welcomed Deya Corzo, M.D., in the position of Vice President, Medical Affairs for the United States as of April 1, 2014.

Hercules Technology Growth Capital Announces Portfolio Update for Q1 2014; Quarter Marked By Continued Portfolio Diversity and Growth and Significant Number of Liquidity Events
Business Wire - Wed Apr 02, 7:02AM CDT
--5 Completed IPO Liquidity Events Q1 2014

uniQure Announces Results for Financial Year 2013
GlobeNewswire - Wed Mar 26, 7:12AM CDT
uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced unaudited results for the financial year ended December 31, 2013. As of December 31, 2013, the Company held cash and cash equivalents of EUR23.8 million.

uniQure to Present at Future Leaders in Biotech Conference
GlobeNewswire - Fri Mar 21, 10:35AM CDT
uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the 21 Annual Future Leaders in the Biotech Industry Conference March 28, 2014, to be held at the Millennium Broadway Hotel, New York City, NY, USA.

uniQure and Chiesi Announce Six Year Follow-up Data from Glybera(r) Treated Patients
GlobeNewswire - Mon Mar 17, 5:18AM CDT
uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, and Chiesi Farmaceutici S.p.A. ("Chiesi", a leading international pharmaceutical company, today announced initial analysis of retrospectively collected individual patient data from LPLD patients treated with Glybera. The analysis covers follow-up data for up to six years post treatment for 13 patients, all of whom met indication requirements for the current labeling of Glybera in the EU. This analysis represents an extension of the case note review which formed a part of the data package upon which the European Commission approved Glybera in October 2012 under exceptional circumstances for the treatment of a subset of patients with lipoprotein lipase deficiency, or LPLD, a potentially life-threatening, orphan metabolic disease. Glybera currently is not approved for use outside of the European Union.

Forbion Announces Closing of Initial Public Offering of Portfolio Company uniQure
Business Wire - Thu Feb 13, 3:30AM CST
Forbion Capital Partners, the leading Dutch VC firm investing in world-class healthcare technologies, is proud to announce that its portfolio company uniQure N.V. (uniQure or the company) has closed its initial public offering of ordinary shares at an initial public offering price of $17.00 per ordinary share. uniQure's ordinary shares are listed on the NASDAQ Global Select Market and began trading under the symbol "QURE" on February 5, 2014. Jefferies LLC and Leerink Partners LLC acted as joint book-running managers and Piper Jaffray & Co. acted as lead manager for the offering.

uniQure Announces Closing of Initial Public Offering
GlobeNewswire - Mon Feb 10, 8:53AM CST
uniQure B.V. ("uniQure", a leader in human gene therapy, today announced the closing of its previously announced initial public offering of 5,400,000 ordinary shares at an initial public offering price of $17.00 per ordinary share. In addition, uniQure granted the underwriters a 30-day option from February 5, 2014 to purchase up to an additional 810,000 ordinary shares from uniQure at the public offering price, less underwriting discounts. uniQure's ordinary shares were approved for listing on the NASDAQ Global Select Market and began trading under the symbol "QURE" on February 5, 2014.

uniQure Announces Pricing of Initial Public Offering
GlobeNewswire - Wed Feb 05, 7:05AM CST
uniQure B.V. ("uniQure", a leader in human gene therapy, today announced the pricing of its initial public offering of 5,400,000 ordinary shares at an initial public offering price of $17.00 per ordinary share. In addition, uniQure has granted the underwriters a 30-day option to purchase up to an additional 810,000 ordinary shares from uniQure at the public offering price, less underwriting discounts. After deducting the underwriting discounts and other estimated offering expenses payable by uniQure, the net proceeds of the initial public offering are expected to be approximately $81.9 million. The offering is expected to close on or about February 10, 2014, subject to customary closing conditions. uniQure's ordinary shares have been approved for listing on the NASDAQ Global Select Market and are expected to begin trading under the symbol "QURE" on February 5, 2014.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 136

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 252

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Priceline's Cyber Week: A Pocket-Friendly Travel Bonanza

Updated Category News Views 134

Unpacking Priceline's Cyber Week Bonanza Alright, folks, grab your booking hats because Priceline is back with its annual Cyber Week extravaganza, aiming to give travelers a shot in the arm of savings just when inflation has everyone pinching pennies. From November 16 through December 2, Priceline rolls out the red carpet for vacation planners, offering eye-popping...

Continue Reading
Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 101

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 49

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 34

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 193

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 17

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 86

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 36

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Mountain Lake Lodge Unveils Exciting 2026 Dance Weekend

Updated Category News Views 875

Virginia's Mountain Lake Lodge Reveals New Weekend Events For fans of the classic film Dirty Dancing, Virginia's Mountain Lake Lodge offers a chance to revisit a piece of cinematic history. As the original filming location, the lodge is thrilled to announce its much-anticipated Dirty Dancing Weekend schedule for 2026, along with plans for the upcoming Summer Festival....

Continue Reading
Regenx Tech Faces Audit Delays and Seeks Management Cease Order

Updated Category News Views 241

Regenx Tech Corporation Faces Filing Delays Regenx Tech Corp, known for pioneering technology in the recycling of end-of-life diesel catalytic converters, is currently navigating through challenges with its annual financial filings. The company, which operates under the ticker symbols CSE: RGX, OTCQB: RGXT, and Frankfurt: YRS, announced that due to delays in completing...

Continue Reading
Foresight Mental Health Launches Innovative Maternal Support Program

Updated Category News Views 133

Foresight Mental Health Launches Innovative Support Program Foresight Mental Health is excited to unveil its groundbreaking Maternal Mental Health Program, a comprehensive initiative aimed at providing expert mental health support across various stages of the reproductive journey. This program is particularly focused on addressing the substantial unmet needs of birthing...

Continue Reading
Navigating Market Uncertainty with Financial Planning

Updated Category News Views 125

Staying Calm Amid Market Chaos The market's like a roller coaster more often than not, and when headlines scream panic, even the most seasoned of us can begin to doubt our strategies. Jennifer Prosise from The Voyager Group, Ltd., in Joliet, IL, calls out this high-stakes game in HelloNation, emphasizing how financial planning serves as our anchor in the stormy seas of...

Continue Reading
Yondr Group Expands with New 550MW Data Center in Dallas

Updated Category News Views 458

Yondr Group's Ambitious Move in the US Market Yondr Group, renowned for its innovative advancements in data center development, has embarked on a groundbreaking project that promises to accelerate its growth in the competitive US market. The company recently acquired a significant 163-acre site near Dallas, Texas, which is set to become home to a massive data center...

Continue Reading